The news is directly related to Veracyte and is likely to influence investor sentiment. While the 'Buy' rating is maintained, the lowering of the price target may indicate a potential decrease in the short-term value of the stock. However, the overall impact is neutral as the 'Buy' rating suggests that the stock is still expected to perform well in the long run.